JP Morgan analyst cuts Freshpet price forecast to $102 while maintaining a Neutral rating. Concerns over changing consumption trends and accuracy of estimates, but strong revenue growth and long-term potential. EBITDA and revenue growth estimates revised.
Latest Ratings for FRPT
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2021 | Citigroup | Maintains | Sell | |
| Dec 2021 | Credit Suisse | Maintains | Neutral | |
| Dec 2021 | Oppenheimer | Maintains | Outperform |
